Oral Oncology

Papers
(The H4-Index of Oral Oncology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma335
Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model96
Authors reply to the comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis70
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review60
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma55
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?51
Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study48
Overestimated risk of transformation in oral lichen planus47
Comment on “Circulating miRNAs as diagnostic biomarkers in HPV-associated oropharyngeal squamous cell carcinoma (OPSCC)”46
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients45
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review43
Revaluation of the treatment of head and neck cancer in Brazil during the COVID-19 pandemic - phase 238
Editorial Board/Aims & Scope36
P28 Head and neck cancer cells differentiate resembling their tissue of origin34
The characteristics and prospects of reflectance confocal microscopy for noninvasive diagnosis of oral potentially malignant disorders33
Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study32
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies32
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]32
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”31
The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD)30
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment30
Squamous odontogenic tumor like proliferations in dentigerous cyst- a great mimicker29
Clinicopathological factors associated with progression of oral submucous fibrosis: A population-based retrospective study29
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection28
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study28
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus–related malignancies28
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis28
Radiation-induced sarcomas of the craniofacial region: A systematic review28
0.10116386413574